adenosine and atl 313
adenosine has been researched along with atl 313 in 7 studies
Research
Studies (7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Deflorian, F; Gao, ZG; Jacobson, KA; Katritch, V; Kumar, TS; Phan, K; Stevens, RC; Wu, H; Xu, F | 1 |
| Donegan, RK; Lieberman, RL | 1 |
| Hurley, DJ; Linden, JM; Moore, JN; Murray, TF; Sun, WC; Vandenplas, ML | 1 |
| Cao, Z; Hurley, DJ; Linden, J; Moore, JN; Murray, TF; Sun, WC; Vandenplas, ML | 1 |
| Gazoni, LM; Kron, IL; Laubach, VE; Linden, J; Unger, EB; Walters, DM | 1 |
| Loram, LC; Maier, SF; Rieger, J; Sloane, E; Strand, KA; Taylor, FR; Van Dam, AM; Watkins, LR | 1 |
| Goehler, LE | 1 |
Reviews
1 review(s) available for adenosine and atl 313
| Article | Year |
|---|---|
Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Adrenergic beta-Antagonists; Animals; Drug Discovery; Glaucoma; Humans; Ligands; Protein Kinase Inhibitors; rho-Associated Kinases; Sympathomimetics | 2016 |
Other Studies
6 other study(ies) available for adenosine and atl 313
| Article | Year |
|---|---|
Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptor.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Amino Acids; Animals; Binding Sites; CHO Cells; Cricetinae; Cricetulus; Crystallography, X-Ray; HEK293 Cells; Humans; Ligands; Models, Molecular; Nucleosides; Phenethylamines; Protein Conformation; Radioligand Assay; Receptor, Adenosine A2A; Stereoisomerism; Structure-Activity Relationship; Thermodynamics | 2012 |
Pharmacologic characterization of novel adenosine A2A receptor agonists in equine neutrophils.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; Cyclic AMP; Horses; Inhibitory Concentration 50; Kinetics; Lipopolysaccharides; Neutrophils; Phenethylamines; Piperidines; Radioligand Assay; Reactive Oxygen Species; Receptor, Adenosine A2A; Xanthines | 2007 |
Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; Cyclic AMP; Horses; Immunoenzyme Techniques; Lipopolysaccharides; Monocytes; Phenethylamines; Piperidines; Receptor, Adenosine A2A; Regression Analysis; Triazines; Triazoles; Tumor Necrosis Factor-alpha | 2008 |
Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; Blood Pressure; Disease Models, Animal; In Vitro Techniques; Lung; Lung Compliance; Lung Diseases; Perfusion; Peroxidase; Piperidines; Protective Agents; Pulmonary Artery; Pulmonary Edema; Rabbits; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A3; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2010 |
Adenosine 2A receptor agonism: A single intrathecal administration attenuates motor paralysis in experimental autoimmune encephalopathy in rats.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Encephalomyelitis, Autoimmune, Experimental; Male; Microglia; Paralysis; Phenethylamines; Piperidines; Rats; Spinal Cord | 2015 |
Commentary: Flipping the switch on chronic pain.
Topics: Adenosine; Animals; Anti-Inflammatory Agents; Chronic Pain; Male; Piperidines; Rats; Sciatic Nerve | 2019 |